13G Filing: Foresite Capital Fund III, L.P. and Tocagen Inc (TOCA)

Page 6 of 9 – SEC Filing

ITEM 4. OWNERSHIP
The following information with respect to the ownership of the common stock of the Issuer by the persons filing this Statement is provided as of April 21, 2017:
(a) Amount beneficially owned:

See Row 9 of cover page for each Reporting Person.
(b) Percent of Class:

See Row 11 of cover page for each Reporting Person.
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote:

See Row 5 of cover page for each Reporting Person.
(ii) Shared power to vote or to direct the vote:

See Row 6 of cover page for each
Reporting Person.

(iii) Sole power to dispose or to direct the disposition of:

See Row 7 of cover page for each
Reporting Person.

(iv) Shared power to dispose or to direct the disposition of:

See Row 8 of cover page for each Reporting Person.
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS

If this statement is being filed to report the fact that as of the date hereof the Reporting Person has ceased to be the beneficial
owner of more than 5 percent of the class of securities, check the following x.
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.

Under certain circumstances set forth in the limited partnership agreement of FCF III and the limited liability company agreement
of FCM III the partners or members, as the case may be, of each of such entities may be deemed to have the right to receive dividends
from, or the proceeds from the sale of, shares of the Issuer directly or indirectly owned by each such entity of which they are
a partner or member.
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING
COMPANY


Not applicable.
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.

Not applicable
ITEM 9. NOTICE OF DISSOLUTION OF GROUP.

Not applicable
ITEM 10. CERTIFICATION.

By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and
are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were
not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than
activities solely in connection with a nomination under § 240.14a-11.

Follow Forte Biosciences Inc. (NASDAQ:FBRX)